Lite Strategy, Inc. — Director's Dealing 2019

Sep 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2019-09-06

Reporting Person: White Christine Anna (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-06	Common Stock	P	15000	$1.7383	Acquired	15000	Direct

Footnotes

F1: The shares purchased by the reporting person are held through an Individual Retirement Account.

F2: The weighted average purchase price for the transaction reported was $1.7383, and the range of prices was between $1.725 and $1.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.